WEISZ, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 9.044
EU - Europa 3.592
AS - Asia 2.335
SA - Sud America 261
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 6
Totale 15.268
Nazione #
US - Stati Uniti d'America 8.999
IT - Italia 1.117
SG - Singapore 822
CN - Cina 777
UA - Ucraina 673
RU - Federazione Russa 534
DE - Germania 411
IE - Irlanda 296
BR - Brasile 242
FI - Finlandia 201
VN - Vietnam 182
KR - Corea 176
HK - Hong Kong 143
SE - Svezia 142
TR - Turchia 119
NL - Olanda 47
IN - India 46
GB - Regno Unito 41
AT - Austria 28
CA - Canada 28
CZ - Repubblica Ceca 25
FR - Francia 19
MX - Messico 14
BD - Bangladesh 13
JP - Giappone 13
EU - Europa 12
CH - Svizzera 10
PL - Polonia 10
IQ - Iraq 8
ES - Italia 7
BE - Belgio 6
AR - Argentina 5
EG - Egitto 5
PK - Pakistan 5
RO - Romania 5
SA - Arabia Saudita 5
AU - Australia 4
EC - Ecuador 4
PH - Filippine 4
ZA - Sudafrica 4
DK - Danimarca 3
PY - Paraguay 3
TW - Taiwan 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BO - Bolivia 2
CO - Colombia 2
ET - Etiopia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KW - Kuwait 2
KZ - Kazakistan 2
MA - Marocco 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GR - Grecia 1
GY - Guiana 1
KE - Kenya 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NG - Nigeria 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.268
Città #
Ann Arbor 2.196
Chandler 1.035
Wilmington 848
Jacksonville 846
Princeton 689
Woodbridge 627
Houston 396
Singapore 291
Dublin 278
Ashburn 272
Salerno 209
Dong Ket 174
Andover 162
Nanjing 158
Hong Kong 139
Boardman 137
Munich 127
Beijing 124
Izmir 102
Moscow 102
Pellezzano 101
Naples 88
Mestre 80
Fairfield 67
Dearborn 60
Shenyang 60
Hebei 57
Düsseldorf 51
Turku 49
Changsha 47
Nanchang 45
Dallas 41
Jiaxing 38
The Dalles 38
Los Angeles 31
Norwalk 31
Columbus 30
Tianjin 29
Washington 27
Guangzhou 26
Jinan 24
Brno 21
Falls Church 20
Nuremberg 20
Redwood City 20
São Paulo 19
Cambridge 18
Matera 17
Pune 17
Fisciano 16
Mercato San Severino 16
New York 16
Nürnberg 16
Potenza 15
Santa Clara 15
Zhengzhou 15
Vienna 14
Lappeenranta 13
San Diego 13
Seattle 13
Shanghai 13
Amsterdam 11
London 11
San Francisco 11
San Jose 11
Brooklyn 10
Tokyo 10
Venezia 10
Boston 9
Milan 9
Atlanta 8
Council Bluffs 8
Helsinki 8
Prineville 8
Rio de Janeiro 8
Sarno 8
Chennai 7
Istanbul 7
Montreal 7
Phoenix 7
Renton 7
Stockholm 7
Campobasso 6
Edinburgh 6
Frankfurt am Main 6
Mele 6
Minneapolis 6
Pisa 6
Tappahannock 6
Warsaw 6
Belo Horizonte 5
Bologna 5
Brasília 5
Cagliari 5
Charlotte 5
Fort Worth 5
Goiânia 5
Hangzhou 5
Hanoi 5
Hefei 5
Totale 10.539
Nome #
Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells 362
iSmaRT: a toolkit for a comprehensive analysis of small RNA-Seq data 163
Identification of Genes Selectively Regulated in Human Hepatoma Cells by Treatment With Dyslipidemic Sera and PUFAs 151
Analysis of gene expression modulation by exposure to low frequency (LF) electric fields 147
Small non-coding RNA deregulation in endometrial carcinogenesis 142
Infantile spasms in early-onset Niemann-Pick disease with a novel compound heterozygous mutations in SMPD1 gene. 134
Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy 134
Small RNA profiling reveals deregulated PTEN/PI3K/Akt pathway in asthmatic bronchial smooth muscle cells. 133
Expression of c-jun acts is not mandatory for mouse hepatocyte proliferation induced by two ligands of nuclear receptors: TCPOBOP and T3. 128
Effect of LF Electric Fields on Gene Expression of Bone Cultured Cells 128
Relationship between mutations in DNA sequences loci coding pre-miRNAs and genes related to biogenesis of sncRNAs with miRNA expression in endometrial carcinoma tissues. 128
DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells 126
Design and expression of peptides with antimicrobial activity against Salmonella typhimurium 125
Single-cell states in the estrogen response of breast cancer cell lines. 122
Global Analysis of Estrogen Receptor Beta Binding to Breast Cancer Cell Genome Reveals Extensive Interplay with Estrogen Receptor Alpha for Target Gene Regulation. 121
Malignant mammary cells acquire independence from extracellular context for regulation of estrogen receptor alpha. 117
LF electric fields exposure of bone cultured cells. Effects on gene expression 115
Genome-wide analysis of unliganded estrogen receptor binding sites in breast cancer cells. 115
Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma 115
Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cells 113
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 113
A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome. 112
Effects of Oestrogen on MicroRNA Expression in Hormone-Responsive Breast Cancer Cells 112
Effect of low frequency (LF) electric fields on gene expression of a bone human cell line. 112
Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells 112
New Insights on Estrogen Receptor Actions in Hormone-responsive Breast Cancer Cells by Interaction Proteomics 111
Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations. 111
Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. 110
Leptin as a Mediator of Tumor-Stromal Interactions Promotes Breast Cancer Stem Cell Activity. 110
The AKT/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells. 109
A large set of estrogen receptor beta-interacting proteins identified by tandem affinity purification in hormone-responsive human breast cancer cells nuclei. 108
MicroRNA (miRNA) and piwi-interacting RNA (piRNA) signature of human primary bronchial epithelial cells (PBEC) after exposure to mainstream cigarette smoke (MCS) 108
Estrogen Receptor α Controls a Gene Network in Luminal-like Breast Cancer Cells Comprising Multiple Transcription Factors and microRNAs. 107
Post-transcriptional regulation of human breast cancer cell proteome by unliganded Estrogen Receptor beta via microRNAs. 107
Timed regulation of P-Element-Induced Wimpy Testis-interacting RNA expression during rat liver regeneration. 105
Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cells. 104
Large-scale profiling of signalling pathways reveals an asthma specific signature in bronchial smooth muscle cells 103
Identification of H ferritin-dependent and independent genes in K562 differentiating cells by targeted gene silencing and expression profiling. 102
Characterisation of mainstream cigarette smoke - induced phenotype in human primary bronchial epithelial cells 101
C/EBPδ gene targets in human keratinocytes. 100
Global transcriptome profiles of Italian Mediterranean buffalo embryos with normal and retarded growth. 100
Estradiol and progesterone receptors in malignant gastrointestinal tumors. 99
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 99
Specific inhibition of NF-Y subunits triggers different cell proliferation defects. 96
Kleefstra-variant syndrome with heterozygous mutations in EHMT1 and KCNQ2 genes: a case report 96
Molecular bases of copper and iron deficiency-associated dyslipidemia: a microarray analysis of the rat intestinal transcriptome. 94
Estrogen Actions in Hormone-responsive Cancer Cells 94
Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional de-repression via c-Jun/c-Fos/Estrogen Receptor (Progesterone Receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. 94
Activation of 'immediate-early' genes by estrogen is not sufficient to achieve stimulation of DNA synthesis in rat uterus. 94
Review of: The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements 94
Atrial myxomas arise from multipotent cardiac stem cells 94
iMir: an integrated pipeline for high-throughput analysis of small non-coding RNA data obtained by smallRNA-Seq. 93
17-beta estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G1-arrested human breast cancer cells 92
Interaction of sodium molybdate with highly purified glucocorticoid receptor. 91
Steroid derivatives for electrophilic affinity labelling of glucocorticoid binding sites: interaction with the glucocorticoid receptor and biological activity. 91
Quantitative mapping of RNA-mediated nuclear Estrogen Receptor β interactome in human breast cancer cells 91
17-beta estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing Erk-1 and -2 MAP kinases activation 90
Identification of a hormone-regulated dynamic actin network associated with estrogen receptor alpha in human breast cancer cell nuclei. 90
DNMT3B mutations in ICF syndrome are associated to epigenetic alterations of microRNAs having targets involved in immune function. 90
Analyse génomique de l'action des oestrogènes dans les cancers du sein hormono-sensibles 89
The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting 88
The reverse transcription inhibitor Abacavir shows anticancer activity in PC3 prostate cancer cell line. 87
Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens. 87
Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: Identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics. 87
Mineralcorticoid receptor from rat kidney. Interaction with heparin and purification to a CBG-free stage. 86
RNA sequencing identifies specific PIWI-interacting small non-coding RNA expression patterns in breast cancer. 86
Pharmacogenomics and analogues of the antitumor agent N6-isopentenyladenosine. 85
DNA methylation dynamic of bone marrow hematopoietic stem cells after allogeneic transplantation 85
Accelerated entry into S phase and increased hepatocyte proliferation in c-jun conditional knock-out mice following administration of the CAR agonist TCPOBOP. 84
MicroRNA Expression Profiling of Hormone-Responsive Human Breast Cancer Cells Lines. 84
Estrogen do not modify MAP kinase-dependent nuclear signalling during stimulation of early G1 progression in human breast cancer cells 83
PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach 83
Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy 83
Identification of proteins associated with ligand-activated estrogen receptor alpha in human breast cancer cell nuclei by tandem affinity purification and nanoLC-MS/MS. 83
Identification of long non‑coding RNA expression patterns useful for molecular‑based classification of type I endometrial cancers 82
Time-course analysis of genome-wide gene expression data from hormone-responsive human breast cancer cells. 81
17beta-Estradiol inhibits forskolin-induced vascular endothelial growth factor promoter in MCF-7 breast adenocarcinoma cells 81
Assay of total estradiol receptor in tissue homogenate and tissue fractions by exchange with sodium thiocyanate at low temperature. 81
Competitive binding assay for glucocorticoids. Influence of experimental conditions on measurement of the affinity of competitive steroids for the receptor. 80
Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells 80
Fetal cardiac growth is associated with in utero gut colonization 80
Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer 80
A combinatorial approach to gene expression analysis: DNA microarrays. 79
Signaling networks associated with AKT activation in Non-Small Cell Lung Cancer (NSCLC): new insights on the role of the catalytic subunit of phosphatydilinositol-3 kinase PIK3CA 79
Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer 79
Enhancement of inducible-type NO synthase gene transcription by protein synthesis inhibitors. Activation of an intracellular signal transduction pathway by low concentrations of cycloheximide. 78
Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes. 78
Analysis of the estrogen-responsive transcriptome from breast cancer cells: a comparative analysis with three different microarray platforms. 78
Differences in miRNA expression profiles between ERβ- and ERβ+ breast tumors in vivo and human breast cancer cell lines in vitro reveal a role of these small non-coding RNAs in the hormone-responsive cancer phenotype. 77
The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading 77
Insulin upregulates VEGF and stabilizes its messenger in endometrial carcinoma cells 75
Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. 75
Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer 75
Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of hormone regulated genes. 74
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukaemia cells. 73
Mechanisms of glucocorticoid hormone action. 71
Functional antagonism between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription. 71
Gene expression analysis of pre-defined sets of neoplastic tissues allows discovery of new genes associated with breast cancer progression. 71
Relations of gut liver axis components and gut microbiota in obese children with fatty liver: A pilot study 71
Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy 71
Totale 10.035
Categoria #
all - tutte 59.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.289 20 134 146 11 152 47 158 14 208 22 167 210
2021/20221.283 22 0 4 17 73 32 27 56 188 163 164 537
2022/20232.420 205 206 89 333 287 460 19 230 400 11 120 60
2023/20241.030 81 141 79 50 69 144 115 57 19 38 40 197
2024/20252.736 75 32 50 86 152 380 465 271 444 106 368 307
2025/2026159 159 0 0 0 0 0 0 0 0 0 0 0
Totale 15.844